Clover Health Investments (NASDAQ:CLOV) Price Target Raised to $4.50

Clover Health Investments (NASDAQ:CLOV) had its target price upped by Canaccord Genuity Group from $4.20 to $4.50 in a report released on Monday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Separately, Craig Hallum assumed coverage on Clover Health Investments in a research note on Tuesday, December 17th. They issued a “buy” rating and a $6.00 target price for the company.

Clover Health Investments Stock Performance

NASDAQ CLOV opened at $3.83 on Monday. The business has a fifty day moving average price of $4.07 and a 200 day moving average price of $3.61. Clover Health Investments has a one year low of $0.61 and a one year high of $4.87. The company has a market cap of $1.92 billion, a P/E ratio of -19.15 and a beta of 2.00.

Hedge Funds Weigh In On Clover Health Investments

A number of hedge funds have recently modified their holdings of the business. Concurrent Investment Advisors LLC purchased a new position in Clover Health Investments during the 3rd quarter valued at about $28,000. Sigma Planning Corp purchased a new position in Clover Health Investments during the 3rd quarter valued at about $29,000. Parallax Volatility Advisers L.P. purchased a new position in Clover Health Investments during the 3rd quarter valued at about $38,000. Forum Financial Management LP boosted its holdings in Clover Health Investments by 33.8% during the 3rd quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock valued at $45,000 after acquiring an additional 4,061 shares during the period. Finally, Triumph Capital Management purchased a new position in Clover Health Investments during the 4th quarter valued at about $45,000. 19.77% of the stock is currently owned by hedge funds and other institutional investors.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.